Virological characteristics of the SARS-CoV-2 KP.2 variant

Virological characteristics of the SARS-CoV-2 KP.2 variant

[...]as of the beginning of April, 2024, the estimated variant frequency of KP.2 has already reached 20% in the UK (appendix p 15). Altogether, these results suggest that the increased immune escape ability of KP.2 contributes to its higher Re compared with JN.1. YKa, KU, YKo, and KO contributed equ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Lancet infectious diseases 2024-07, Vol.24 (7), p.e416-e416
Hauptverfasser: Kaku, Yu, Uriu, Keiya, Kosugi, Yusuke, Okumura, Kaho, Yamasoba, Daichi, Uwamino, Yoshifumi, Kuramochi, Jin, Sadamasu, Kenji, Yoshimura, Kazuhisa, Asakura, Hiroyuki, Nagashima, Mami, Ito, Jumpei, Sato, Kei
Format: Artikel
Sprache:eng
Schlagworte:
Consortia
Proteins
R&D
Research & development
Severe acute respiratory syndrome coronavirus 2
Vaccines
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[...]as of the beginning of April, 2024, the estimated variant frequency of KP.2 has already reached 20% in the UK (appendix p 15). Altogether, these results suggest that the increased immune escape ability of KP.2 contributes to its higher Re compared with JN.1. YKa, KU, YKo, and KO contributed equally to this study.
ISSN:1473-3099
1474-4457
1474-4457
DOI:10.1016/S1473-3099(24)00298-6